USPTO serial 78857203
ABRAXIS PHARMACEUTICAL PRODUCTS
Reviewed by CopyMark Law Group
Reg. 3309636Status 710
- Filing date
- Status date
- Registration date
- Oct 9, 2007
- Examiner
- GAST, PAUL
- Law office
- TMEG LAW OFFICE 106
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with ABRAXIS PHARMACEUTICAL PRODUCTS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Los Angeles, CA
Los Angeles, CA
Los Angeles, CA
Summit, NJ
American Pharmaceutical Partners, Inc.
Schaumburg, IL
Other trademarks owned by American Pharmaceutical Partners, Inc.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Camille M. Miller
Camille M. Miller COZEN O'CONNOR1650 MARKET STOne Liberty PlacePHILADELPHIA, PA 19103-3527Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals, namely, alkalizing agents, analgesics and anesthetics, antacids, anticholinergics, antihistamines, anti-infectives, anti-inflammatory agents, anticonvulsants, antidotes, antiemetics, antipsychotics, anxiolytics, blood modifiers, bronchodialators, cardiovasculars, diuretics, hormones, diluents, electrolytes, trace element preparations in the nature of mineral supplements for human consumption, vitamins, micronutrients, namely, nutritional supplements, oncolytics, immunosuppressive agents, transplantation agents, imaging agents, vascular targeting agents, and sensitizing agents for chemotherapy-resistant tumors; pharmaceuticals for treatment of cancer; pharmaceuticals to treat vascular diseases; drug delivery systems composed of nanoparticles sold as an integral component of drugs; injectable drugs and therapeutic solutions for the treatment of cancer and vascular diseases in the form of prefilled IV bags as a unit, sold separately or with devices for intravenous administration, namely, transfer pins, vials, needles, adaptors and tamper resistant seals sold as a kit | SECTION 8 - CANCELLED | May 1, 2006 |
| 035 | distributorship and retail ordering services featuring pharmaceuticals, namely, alkalizing agents, analgesics and anesthetics, antacids, anticholinergics, antihistamines, anti-infectives, anti-inflammatory agents, anticonvulsants, antidotes, antiemetics, antipsychotics, anxiolytics, blood modifiers, bronchodialators, cardiovasculars, diuretics, hormones, diluents, electrolytes, trace elements, vitamins, micronutrients, oncolytics, immunosuppressive agents, transplantation agents, imaging agents, vascular targeting agents, and sensitizing agents for chemotherapy-resistant tumors; distributorship and retail ordering services featuring pharmaceuticals for the treatment of cancer, pharmaceuticals to treat vascular diseases, drug delivery systems composed of nanoparticles sold as an integral component of drugs; distribution and retail ordering services featuring IV bags for presentation with injectable drugs or therapeutic solutions and devices for intravenous administration of pharmaceuticals, namely, transfer pins, vials, needles, pumping chamber sets, lubricants, adaptors and tamper resistant seals | SECTION 8 - CANCELLED | May 1, 2006 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Abraxis Bioscience, Inc.
- Other trademarks owned by Abraxis Bioscience, Inc.
- Other trademarks owned by Abraxis Bioscience, Inc.
- Other trademarks owned by ABRAXIS BIOSCIENCE, LLC
- Other trademarks owned by American Pharmaceutical Partners, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 035
- Similar marks named ABRAXIS PHARMACEUTICAL PRODUCTS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 11, 2018 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Oct 9, 2016 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Jan 25, 2016 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 25, 2016 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 27, 2015 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 31, 2012 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Oct 31, 2012 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Oct 31, 2012 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 10, 2012 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Oct 15, 2010 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 15, 2010 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 5, 2007 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Oct 9, 2007 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 6, 2007 | REGV | LAW OFFICE REGISTRATION REVIEW COMPLETED | — |
| Sep 6, 2007 | ALIE | ASSIGNED TO LIE | — |
| Jul 29, 2007 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jul 2, 2007 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jul 2, 2007 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 8, 2007 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 8, 2007 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 7, 2007 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 7, 2007 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 3, 2007 | IUAF | USE AMENDMENT FILED | — |
| Apr 3, 2007 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Dec 12, 2006 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 19, 2006 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 30, 2006 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 27, 2006 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 27, 2006 | ALIE | ASSIGNED TO LIE | — |
| Jul 6, 2006 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 6, 2006 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 6, 2006 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 6, 2006 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 1, 2006 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jun 20, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 20, 2006 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 20, 2006 | CEPE | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED | — |
| Jun 20, 2006 | ALIE | ASSIGNED TO LIE | — |
| Jun 19, 2006 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Jun 19, 2006 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| Jun 13, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 7, 2006 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Apr 18, 2006 | NWAP | NEW APPLICATION ENTERED | — |